Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM1)
This study is currently recruiting participants.
Study NCT00671528 Information provided by Schering-Plough
First Received: May 1, 2008 Last Updated: September 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dermatitis, Atopic
Eczema, Atopic
Skin Diseases, Eczematous
Additional conditions recognized in this trial
Dermatitis
Eczema
Skin Diseases
More general conditions related to this trial
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases, Genetic
Interventions listed in this trial
Cream (betamethasone diproprionate)
Additional drug interventions recognized in this trial
Betamethasone
Betamethasone sodium phosphate
Betamethasone-17,21-dipropionate
Clotrimazole
Gentamicins
Miconazole
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Local
Anti-Inflammatory Agents
Antifungal Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protein Synthesis Inhibitors
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Schering-Plough
Back to top of Main Content
